Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced a $1 million programmatic investment in Satellos Bioscience to support the development of a new regenerative medicine for the therapeutic treatment of Duchenne.